Health ❯ Healthcare ❯ Cancer

Cancer Treatment

Immunotherapy Chemotherapy Clinical Trials CAR T-cell Therapy Palliative Care Patient Support Early Detection Cancer Vaccines Mental Health Survival Rates Remission Personalized Medicine Synovial Sarcoma Exercise Benefits Therapeutic Vaccines Prostate Cancer Patient Advocacy Radiation Therapy Cancer Survivorship Royal Marsden Hospital Patient Experience Weight-loss Medications Kidney Cancer Colon Cancer Complications Targeted Drug Delivery Frozen Section Procedure Patient Outcomes Therapeutic Strategies Royal Family Health Issues Cancer Patient Care Melanoma Melanoma Vaccine Radioactive Iodine Therapy Cancer Immunotherapy Financial Toxicity Physical Activity Ferroptosis Inhibitors mRNA Vaccination Immunotherapy Resistance T-cell Therapy Medication Pricing Solid Tumors Misinformation Hormone Therapy Esophageal Adenocarcinoma Patient Care Chemotherapy Drugs NHS Targets Therapeutics Immunotherapy Efficacy Genetics iNKT Cell Therapy Royal Family Health Patient Support Services Survivorship Medical Technology Cancer Awareness End-of-Life Care Proton Therapy National Cancer Plan CD40 Agonist Antibodies Radiotherapy Awareness Targeted Therapy Cancer Stem Cells Pain Management Mind-Body Therapies HPV-positive Throat Cancer Nutrition Therapy Immune Response Therapeutic Cancer Vaccines Statistics Cancer Hospitals Day Care Cancer Centres Bureaucracy in Healthcare Oncology and Diabetes Integration Exercise and Cancer Antibody-Drug Conjugates Patient Statistics Theranostics Access to Treatment Recovery Cachexia Innovative Therapies Impact on Disability Assessment Smoking Cessation Oncology Drug Pricing NUC-7738 Personal Stories Early Diagnosis Experimental Drugs Screening Methods PARP Inhibitors NHS Cancer Plan Preventive Care Support for Patients Patient Safety Screening Drug Resistance

U.S. Cancer Survival Hits 70% as ACS Warns Progress Is at Risk

The latest ACS report projects about 2.1 million new cases and 626,000 deaths in 2026.

San Francisco Leaders Press Blue Shield Over Retired Firefighter’s Cancer Coverage

U.S. Cancer Survival Reaches 70% in New ACS Report

Immunotherapy Before 3 p.m. Linked to Longer Survival in Small Cell Lung Cancer

CRISPR Knockout of NRF2 Reverses Chemotherapy Resistance in Lung Cancer Models

mRNA COVID Vaccination Linked to Longer Survival With Cancer Immunotherapy, Data Presented at ESMO

Quitting After Cancer Diagnosis Linked to Higher Two-Year Survival, JNCCN Study Finds

Nanovaccine Targeting Cancer Stem Cells Cuts Post-Surgery Recurrence in Lab Models

HIIT and Weights Spur Anti-Cancer Signals in Blood, Lab Tests Show in Breast Cancer Survivors

Phil and Penny Knight Donate Record $2 Billion to OHSU to Create Self-Governed Knight Cancer Group

Julia Lemigova Reaffirms Pro-Surrogacy Stance, Distances from Navratilova

Phase 3 Trial Validates Low-Dose Olanzapine for Chemo-Induced Nausea Without Heavy Sedation

COVID-19 Boosters Cut Severe Outcomes by Nearly 30% in Cancer Patients

Genome Doubling Shields Ovarian Tumors From Immune Attack and Drives Their Evolution

Exercise-Induced Formate from Gut Microbes Enhances Cancer Immunotherapy

Nearly Half of Early-Stage Breast Cancer Patients Extend Hormone Therapy to Ten Years

Preoperative Exercise Strengthens Tumor Immunity and Reveals Early Remission Signals in OPTIMUS Trial

Structured exercise rivals drug efficacy in slashing colon cancer recurrence and mortality

Next-Generation CAR-T Therapies Deliver Remission in T-Cell Cancers and Extend Survival in Gastric and Brain Tumors

Study Finds NAD Decline Drives Age-Related CAR-T Cell Therapy Failures